Showing results (151-160 of 427) with videos related to

Sort By:
Pageof 43
Future Oncology (London, England)|July 24, 2014
Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patientsCarlo Buonerba, Piera Federico, Davide Bosso, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 18, 2024
Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapyGuglielmo Mantica, Francesca Ambrosini, Giovanni Drocchi, et al.
Oncotarget|October 30, 2016
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillanceMatteo Ferro, Giuseppe Lucarelli, Dario Bruzzese, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2019
Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer: A Propensity Score AnalysisGiulia Marvaso, Delia Ciardo, Sara Gandini, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future PerspectivesOctavian Sabin Tătaru, Mihai Dorin Vartolomei, Jens J Rassweiler, et al.
Metabolites|December 16, 2020
Integration of Lipidomics and Transcriptomics Reveals Reprogramming of the Lipid Metabolism and Composition in Clear Cell Renal Cell CarcinomaGiuseppe Lucarelli, Matteo Ferro, Davide Loizzo, et al.
Urologic Oncology|September 20, 2020
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidatesClaudia Collà Ruvolo, Lara Franziska Stolzenbach, Luigi Nocera, et al.
Plos One|October 8, 2015
Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance ImagingOttavio de Cobelli, Daniela Terracciano, Elena Tagliabue, et al.
Urologic Oncology|July 1, 2020
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic samplingStefano Luzzago, Giuseppe Petralia, Duilia Maresca, et al.
Expert Opinion on Biological Therapy|July 28, 2016
The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic reviewGiuseppe Di Lorenzo, Sabino De Placido, Martina Pagliuca, et al.
Pageof 43